NASDAQ:CASI
CASI Pharmaceuticals Stock News
$2.80
+0.115 (+4.29%)
At Close: May 03, 2024
CASI Pharmaceuticals Earnings Preview
10:03am, Thursday, 11'th Nov 2021
CASI Pharmaceuticals (NASDAQ:CASI) is set to give its latest quarterly earnings report on Friday, 2021-11-12. Here's what investors need to know before the announcement.
CASI Pharmaceuticals, Inc. (CASI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
04:06pm, Monday, 01'st Nov 2021
CASI Pharmaceuticals, Inc. (CASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CASI Pharma (CASI) Sees Hammer Chart Pattern: Time to Buy?
10:30am, Wednesday, 06'th Oct 2021
CASI Pharma (CASI) has been struggling lately, but the selling pressure may be coming to an end soon.
CASI Pharmaceuticals, Inc. To Participate In Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
07:00am, Monday, 20'th Sep 2021
ROCKVILLE, Md. and BEIJING, Sept.
Penny Stocks For Your Biotech Watch List In September 2021
11:04am, Wednesday, 15'th Sep 2021
Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.
Trending Penny Stocks To Buy For Under $3 Right Now
09:29am, Monday, 23'rd Aug 2021
Are these penny stocks worth the risk? The post Trending Penny Stocks To Buy For Under $3 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
CASI Pharmaceuticals Shares Increase Over 15% Pre-Market: Why It Happened
06:23am, Monday, 23'rd Aug 2021
The shares of CASI Pharmaceuticals, Inc. (Nasdaq: CASI) increased by over 16% pre-market. This is why it happened.
CASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q2 2021 Results - Earnings Call Transcript
11:59am, Friday, 13'th Aug 2021
CASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q2 2021 Results - Earnings Call Transcript
CASI Pharmaceuticals To Report Second Quarter 2021 Financial Results And Host Conference Call August 12, 2021
07:00am, Tuesday, 10'th Aug 2021
ROCKVILLE, Md. and BEIJING, Aug. 10, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutic
Analysts Estimate CASI Pharmaceuticals, Inc. (CASI) to Report a Decline in Earnings: What to Look Out for
04:46pm, Monday, 02'nd Aug 2021
CASI Pharmaceuticals, Inc. (CASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractory Multiple Myeloma
07:00am, Thursday, 10'th Jun 2021
ROCKVILLE, Md. and BEIJING, June 10, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics
CASI Pharmaceuticals, Inc. To Participate In Jefferies Virtual Healthcare Conference
07:00am, Thursday, 27'th May 2021
ROCKVILLE, Md. and BEIJING, May 27, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics
Oppenheimer Has 5 Sizzling Biotech Stocks to Buy Now Trading Under $10
06:15am, Saturday, 22'nd May 2021
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
CASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q1 2021 Results - Earnings Call Transcript
04:56pm, Wednesday, 19'th May 2021
CASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q1 2021 Results - Earnings Call Transcript
CASI Pharmaceuticals To Report First Quarter 2021 Financial Results And Host Conference Call May 13, 2021
07:00am, Tuesday, 11'th May 2021
ROCKVILLE, Md. and BEIJING, May 11, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics
